Evidence map›Paper›PMID 35277158›Full record

ArticleBMC complementary medicine and therapies2022

Antimicrobial potential of four mica drugs and their chemical and mineralogical properties.

Apsara Wijenayake, Charmalie Abayasekara, Amarasooriya Pitawala, B M Ratnayake Bandara

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Apsara WijenayakePostgraduate Institute of Science, University of Peradeniya, Peradeniya, Sri Lanka. apsarauwijenayake@gmail.com.
Charmalie AbayasekaraPostgraduate Institute of Science, University of Peradeniya, Peradeniya, Sri Lanka.
Amarasooriya PitawalaPostgraduate Institute of Science, University of Peradeniya, Peradeniya, Sri Lanka.
B M Ratnayake BandaraPostgraduate Institute of Science, University of Peradeniya, Peradeniya, Sri Lanka.
University of Peradeniya · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMica drugs, a group of herbo-metallic traditional preparations comprising biotite mica as the major mineral ingredient, are prescribed for skin disorders and respiratory ailments and other chronic conditions in South Asian countries, particularly India and Sri Lanka. Mica-based drugs (Abhrak drugs) are subjected to unique and varied preparation procedures and the bioactivity of the drugs can be affected by drug-processing conditions, the ingredients used and the mica composition. The current study aimed to evaluate and compare, on the basis of their physical and chemical characteristics, the antimicrobial potential of two commercial mica drugs AbBb (Abhrak bhashma) and AbCh (Abhrak Chenhuram) and two mica drugs ABL1 (Abhrak Bhasma Laboratory Prepared 1) and ABL2 (Abhrak Bhasma Laboratory Prepared 2) prepared in the laboratory under different conditions.

methodsAntimicrobial activity of all four drugs was assessed at 10 mg/ml concentration against Pseudomonas aeruginosa, Escherischia coli, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA) and Candida albicans using well diffusion assay, agar dilution assay and Miles and Misra method. Major and trace metal constituents of the drug samples were measured using atomic absorption spectrometry. Mineralogical properties, bacteria-mineral interactions, morphological changes in microbes and the surface characteristics of the drugs were determined using X-ray diffraction (XRD) analysis and scanning electron microscopy (SEM).

resultsThe drugs ABL1, ABL2 and AbBh exhibited antimicrobial activity against only Gram-positive organisms (S. aureus and MRSA) when tested with Miles and Misra method (broth method). Mineralogical studies (XRD) revealed that biotite mica was altered into secondary clay minerals and iron oxides in the commercial drug AbCh while the other three drugs had altered mica and iron oxide phases. The essential elements (Na, K, Ca and Mg) required for microbial functions were present in varying extents in all four drugs while they were present in exceedingly high amounts in AbCh having comparatively high cation-exchange capacity, consistent with the observation that AbCh was inactive against all the microbes tested. The three drugs (ABL1, ABL2 and AbBh) showing antimicrobial activity contained comparatively high amounts of Fe, Zn and Cu that are known to display antimicrobial properties at high concentrations. SEM studies revealed that the drug particles adhered and entrapped the bacterial species, presumably modifying the physiochemical characteristics of the bacteria and eventually causing lethality.

conclusionThree of the four mica drugs inhibited the tested Gram-negative bacteria and the antibacterial activity of the mica drugs depends on their constituents and the methods of preparation.

Indexed as

Anti-Infective AgentsMethicillin-Resistant Staphylococcus aureusAluminum SilicatesAnti-Bacterial AgentsStaphylococcus aureusAluminum SilicatesAnti-Bacterial AgentsAnti-Infective AgentsmicaAntimicrobialBhasmaBiotiteMica drugsRasashastraTraditional medicine

Identifiers

PMID35277158
PMCPMC8917772
OpenAlexW4220714978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.